To better understand the stage(s) of differentiation reached by B-type chronic lymphocytic leukemia (B-CLL) cells and to gain insight into the potential role of antigenic stimulation in the development and diversification of these cells, we analyzed the rearranged VH genes expressed by 83 B-CLL cells (64 IgM+ and 19 non-IgM+). Our results confirm and extend the observations of a bias in the use of certain VH, D, and JH genes among B-CLL cells. In addition, they indicate that the VH genes of approximately 50% of the IgM+ B-CLL cells and approximately 75% of the non-IgM+ B-CLL cells can exhibit somatic mutations. The presence of mutation varies according to the VH family expressed by the B-CLL cell (VH3 expressers displaying more mutation than VH1 and VH4 expressers). In addition, the extent of mutation can be sizeable with approximately 32% of the IgM+ cases and approximately 68% of the non-IgM+ cases differing by > 5% from the most similar germline gene. Approximately 20% of the mutated VH genes display replacement mutations in a pattern consistent with antigen selection. However, CDR3 characteristics (D and JH gene use and association and HCDR3 length, composition, and charge) suggest that selection for distinct B cell receptors (BCR) occurs in many more B-CLL cells. Based on these data, we suggest three prototypic BCR, representing the VH genes most frequently encountered in our study. These data suggest that many B-CLL cells have been previously stimulated, placing them in the "experienced" or "memory" CD5(+) B cell subset.
F Fais, F Ghiotto, S Hashimoto, B Sellars, A Valetto, S L Allen, P Schulman, V P Vinciguerra, K Rai, L Z Rassenti, T J Kipps, G Dighiero, H W Schroeder Jr, M Ferrarini, N Chiorazzi
Title and authors | Publication | Year |
---|---|---|
Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies
DG Efremov, S Turkalj, L Laurenti |
Cancers | 2020 |
B cell signalling pathways—New targets for precision medicine in chronic lymphocytic leukaemia
SS Skånland, L Karlsen, K Taskén |
Scandinavian Journal of Immunology | 2020 |
Celebrating 20 Years of IGHV Mutation Analysis in CLL:
N Chiorazzi, FK Stevenson |
2020 | |
CLL intraclonal fractions exhibit established and recently acquired patterns of DNA methylation
BA Bartholdy, X Wang, XJ Yan, M Pascual, M Fan, J Barrientos, SL Allen, JA Martinez-Climent, KR Rai, N Chiorazzi, MD Scharff, S Roa |
Blood Advances | 2020 |
B Cell Receptor Immunogenetics in B Cell Lymphomas: Immunoglobulin Genes as Key to Ontogeny and Clinical Decision Making
K Gemenetzi, A Agathangelidis, L Zaragoza-Infante, E Sofou, M Papaioannou, A Chatzidimitriou, K Stamatopoulos |
Frontiers in Oncology | 2020 |
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia
A Lupia, S Mimmi, E Iaccino, D Maisano, F Moraca, C Talarico, E Vecchio, G Fiume, F Ortuso, G Scala, I Quinto, S Alcaro |
European Journal of Medicinal Chemistry | 2020 |
Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients
A Bosseboeuf, C Seillier, N Mennesson, S Allain-Maillet, M Fourny, A Tallet, E Piver, P Lehours, F Mégraud, L Berthelot, J Harb, E Bigot-Corbel, S Hermouet |
Frontiers in immunology | 2020 |
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients
P Monti, M Lionetti, GD Luca, P Menichini, AG Recchia, S Matis, M Colombo, S Fabris, A Speciale, M Barbieri, M Gentile, S Zupo, M Dono, A Ibatici, A Neri, M Ferrarini, F Fais, G Fronza, G Cutrona, F Morabito |
Scientific Reports | 2020 |
Non-Hodgkin Lymphomas: Malignancies Arising from Mature B Cells
J Shingleton, J Wang, C Baloh, T Dave, N Davis, L Happ, O Jadi, R Kositsky, X Li, C Love, R Panea, Q Qin, A Reddy, N Singhi, E Smith, D Thakkar, SS Dave |
Cold Spring Harbor Perspectives in Medicine | 2020 |
Evaluation of Somatic Hypermutation Status in Chronic Lymphocytic Leukemia (CLL) in the Era of Next Generation Sequencing
SK Gupta, DS Viswanatha, KP Patel |
Frontiers in Cell and Developmental Biology | 2020 |
Precision Medicine Management of Chronic Lymphocytic Leukemia
R Moia, A Patriarca, M Schipani, V Ferri, C Favini, S Sagiraju, WA Essa, G Gaidano |
Cancers | 2020 |
Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multi-center study
AC Leeksma, P Baliakas, T Moysiadis, A Puiggros, K Plevova, AM der Kevie-Kersemaekers, H Posthuma, AE Rodriguez-Vicente, AN Tran, G Barbany, L Mansouri, R Gunnarsson, H Parker, EV den Berg, M Bellido, Z Davis, M Wall, I Scarpelli, A Österborg, L Hansson, M Jarosova, P Ghia, P Poddighe, B Espinet, S Pospisilova, C Tam, L Ysebaert, F Nguyen-Khac, D Oscier, C Haferlach, J Schoumans, M Stevens-Kroef, E Eldering, K Stamatopoulos, R Rosenquist, JC Strefford, C Mellink, AP Kater |
Haematologica | 2020 |
Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approach
M Colombo, D Bagnara, D Reverberi, S Matis, M Cardillo, R Massara, L Mastracci, JL Ravetti, L Agnelli, A Neri, M Mazzocco, M Squillario, AN Mazzarello, G Cutrona, A Agathangelidis, K Stamatopoulos, M Ferrarini, F Fais |
Molecular Medicine | 2020 |
Chronic Lymphocytic Leukemia-Induced Humoral Immunosuppression: A Systematic Review
E Grywalska, M Zaborek, J Łyczba, R Hrynkiewicz, D Bębnowska, R Becht, B Sosnowska-Pasiarska, J Smok-Kalwat, M Pasiarski, S Góźdź, J Roliński, P Niedźwiedzka-Rystwej |
Cells | 2020 |
HLA allele repertoire in Russian chronic lymphocytic leukemia patients with an unfavorable prognosis
BV Biderman, EB Likold, AR Abdrakhimova, EA Leonov, EG Khamaganova, AB Sudarikov |
2020 | |
Assessing prognosis of chronic lymphocytic leukemia using biomarkers and genetics
R Moia, A Patriarca, AM Mahmoud, V Ferri, C Favini, S Rasi, C Deambrogi, G Gaidano |
Expert Opinion on Orphan Drugs | 2020 |